G1 Therapeutics, Inc. Insider Trading for December 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in G1 Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in G1 Therapeutics, Inc. for December 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 29 2020 | GTHX | G1 Therapeutics, I ... | RUDNICK SETH | Sell | S | 20.10 | 924 | 18,572 | 5,266 | 6.2 K to 5.3 K (-14.93 %) | |
| Dec 29 2020 | GTHX | G1 Therapeutics, I ... | RUDNICK SETH | Sell | S | 20.10 | 924 | 18,572 | 5,266 | 6.2 K to 5.3 K (-14.93 %) | |
| Dec 23 2020 | GTHX | G1 Therapeutics, I ... | RUDNICK SETH | Sell | S | 20.18 | 13,118 | 264,757 | 6,190 | 19.3 K to 6.2 K (-67.94 %) | |
| Dec 23 2020 | GTHX | G1 Therapeutics, I ... | RUDNICK SETH | Sell | S | 20.33 | 18,974 | 385,702 | 19,308 | 38.3 K to 19.3 K (-49.56 %) | |
| Dec 17 2020 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Option Exercise | M | 3.72 | 10,000 | 37,200 | 89,433 | |
| Dec 17 2020 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Option Exercise | M | 3.72 | 10,000 | 37,200 | 99,433 | |
| Dec 17 2020 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Option Exercise | M | 3.72 | 10,000 | 37,200 | 109,433 | |
| Dec 17 2020 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Sell | S | 19.97 | 10,000 | 199,668 | 37,000 | 47 K to 37 K (-21.28 %) |
| Dec 17 2020 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Buy | M | 3.72 | 10,000 | 37,200 | 47,000 | 37 K to 47 K (+27.03 %) |
| Dec 17 2020 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Sell | S | 19.20 | 10,000 | 192,021 | 37,000 | 47 K to 37 K (-21.28 %) |
| Dec 17 2020 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Buy | M | 3.72 | 10,000 | 37,200 | 47,000 | 37 K to 47 K (+27.03 %) |
| Dec 17 2020 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Sell | S | 19.43 | 10,000 | 194,297 | 37,000 | 47 K to 37 K (-21.28 %) |
| Dec 17 2020 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Buy | M | 3.72 | 10,000 | 37,200 | 47,000 | 37 K to 47 K (+27.03 %) |
| Dec 11 2020 | GTHX | G1 Therapeutics, I ... | Malik Rajesh | Ch. Medical Officer ... | Option Exercise | M | 4.17 | 9,000 | 37,530 | 56,519 | |
| Dec 11 2020 | GTHX | G1 Therapeutics, I ... | Malik Rajesh | Ch. Medical Officer ... | Sell | S | 20.06 | 9,000 | 180,550 | 29,200 | 38.2 K to 29.2 K (-23.56 %) |
| Dec 11 2020 | GTHX | G1 Therapeutics, I ... | Malik Rajesh | Ch. Medical Officer ... | Buy | M | 4.17 | 9,000 | 37,530 | 38,200 | 29.2 K to 38.2 K (+30.82 %) |
| Dec 11 2020 | GTHX | G1 Therapeutics, I ... | Malik Rajesh | Ch. Medical Officer ... | Option Exercise | M | 4.17 | 9,000 | 37,530 | 56,519 | |
| Dec 11 2020 | GTHX | G1 Therapeutics, I ... | Malik Rajesh | Ch. Medical Officer ... | Sell | S | 20.06 | 9,000 | 180,550 | 29,200 | 38.2 K to 29.2 K (-23.56 %) |
| Dec 11 2020 | GTHX | G1 Therapeutics, I ... | Malik Rajesh | Ch. Medical Officer ... | Buy | M | 4.17 | 9,000 | 37,530 | 38,200 | 29.2 K to 38.2 K (+30.82 %) |
| Dec 10 2020 | GTHX | G1 Therapeutics, I ... | RUDNICK SETH | Sell | S | 20.00 | 546 | 10,921 | 38,282 | 38.8 K to 38.3 K (-1.41 %) | |
| Dec 10 2020 | GTHX | G1 Therapeutics, I ... | RUDNICK SETH | Sell | S | 20.32 | 5,773 | 117,284 | 38,828 | 44.6 K to 38.8 K (-12.94 %) | |
| Dec 10 2020 | GTHX | G1 Therapeutics, I ... | RUDNICK SETH | Sell | S | 20.19 | 13,161 | 265,694 | 44,601 | 57.8 K to 44.6 K (-22.78 %) | |
| Dec 03 2020 | GTHX | G1 Therapeutics, I ... | RUDNICK SETH | Sell | S | 20.09 | 520 | 10,449 | 57,762 | 58.3 K to 57.8 K (-0.89 %) |